Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

August 31, 2018

Conditions
Polycythemia Vera
Interventions
OTHER

questionnaires

• Influence of iron parameters on Patient-reported symptoms as assessed by Myeloproliferative Neoplasm Symptom Assessment Form Total Symptom Score (MPN-SAF TSS) for assessment of the severity of symptoms, Quality of life evaluation by The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) and fatigue assessment by PROMIS Fatigue Scale: Short Form

Trial Locations (12)

Unknown

Emek Medical center, Afula

Soroka medical center, Beersheba

Hillel Yaffe Medical Center, Hadera

Bnei Zion medical center, Haifa

Rambam Medical center, Haifa

Meir Medical center, Kfar Saba

Sheba medical center, Ramat Gan

Kaplan medical center, Rehovot

Ziv Medical center, Safed

Maccabi, Tel Aviv

Tel Aviv Sourasky, Tel Aviv

Assaf Harofeh Medical Center, Ẕerifin

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Meir Medical Center

OTHER

lead

Rambam Health Care Campus

OTHER

NCT02809274 - Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features | Biotech Hunter | Biotech Hunter